Pursuing the impact of headaches in patients with idiopathic intracranial hypertension: a prospective cohort study
- 22 May 2025
- journal article
- Published by Taylor & Francis in Neurological Research
- p. 1-9
Abstract
Persistent headaches have been reported in a significant percentage of patients with idiopathic intracranial hypertension (IIH). This study aimed to evaluate possible factors underlying post-IIH headache. IIH patients were evaluated for demographic and clinical features, along with the Headache Impact Test (HIT-6) and Migraine Disability Assessment Scale (MIDAS) questionnaires to assess headache-related impact and disability. Features noted at the initial visit were compared with those at follow-up after resolution of papilledema. Of the 91 patients included, 92.3% reported headaches at the initial visit, with 73.8% having headaches consistent with migraine. After resolution of papilledema, 54.9% continued to report headaches. Median HIT-6 and MIDAS scores at follow-up were significantly lower than at the first visit (p < 0.001 for both). On univariate regression analysis, none of the demographic or clinical features investigated, including CSF opening pressure, were associated with post-resolution headaches (p > 0.05). Higher HIT-6 and MIDAS scores at the first visit were associated with higher scores at follow-up (p < 0.05). Cerebrospinal fluid opening pressure was not linked to the presence or impact of post-resolution headaches (p > 0.05). Prior to IIH, 73.6% of patients reported headaches, with 73.1% of these consistent with migraine. Prior migraine was associated with higher HIT-6 and MIDAS scores at the initial visit (p = 0.02 and p < 0.001, respectively). Migraine headaches before IIH diagnosis are associated with more severe and disabling headaches initially. Higher initial HIT-6 or MIDAS scores predict increased disability post-resolution. Headache-specific treatments should be further explored in patients with IIH.Keywords
This publication has 31 references indexed in Scilit:
- The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomesJournal of Neurology, 2022
- Long term outcomes of idiopathic intracranial hypertension: Observational study and literature reviewClinical Neurology and Neurosurgery, 2021
- A novel excel sheet conversion tool from Snellen fraction to LogMAR including ‘counting fingers’, ‘hand movement’, ‘light perception’ and ‘no light perception’ and focused review of literature of low visual acuity reference valuesActa Ophthalmologica, 2020
- Headaches in Idiopathic Intracranial HypertensionJournal of Neuro-Ophthalmology, 2019
- Understanding idiopathic intracranial hypertension: mechanisms, management, and future directionsThe Lancet Neurology, 2016
- The course of headache in idiopathic intracranial hypertension: a 12‐month prospective follow‐up studyEuropean Journal of Neurology, 2014
- The Idiopathic Intracranial Hypertension Treatment TrialJAMA Neurology, 2014
- Idiopathic intracranial hypertension is not benign: a long-term outcome studyJournal of Neurology, 2011
- A randomised controlled trial of treatment for idiopathic intracranial hypertensionJournal of Neurology, 2010
- Idiopathic intracranial hypertension headacheCurrent Pain and Headache Reports, 2002